Cancer, multiple sclerosis, Ebola treatments in new WHO Essential Medicines List
HQ Team July 26, 2023: Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team July 26, 2023: Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to.
HQ Team July 26, 2023: An unusual rise in cases of Guillain-Barré Syndrome (GBS), a rare neurological disorder, has been reported from Peru,.
HQ Team July 26, 2023: Better access to testing and diagnostic services is required to prevent sexually transmitted infections (STI) being acquired by.
HQ Team July 25, 2023: At least 2.5 million people died because of drowning in the last decade and 90% of these deaths.
HQ Team July 25, 2023: Switzerlandâs healthcare company, Roche, signed a pact with US-based Alnylam to jointly develop and commercialize a therapy to.
HQ Team July 25, 2023: Sixty-seven percent of Sudanâs hospitals are out of service and 10 healthcare workers have died in the internal.
HQ Team July 25, 2023: The Middle East Respiratory Syndrome Coronavirus has killed 12 people in the UAE and infected 94 others from.
HQ Team July 24, 2023: British pharmaceutical firm, GSK Plc., has got marketing authorization from the European Medicines Authority for its injectable, and.
HQ Team July 24, 2023: The reliance of countries on external support for funding initiatives to combat HIV is worrisome, and though new.
HQ Team July 21, 2023: Emergent BioSolutions Inc., a US developer of vaccines for infectious diseases, announced its anthrax vaccine has been approved.